Analyst Ratings for Spring Works Therapeutics (SWTX)

SWTX Rating Summary

SWTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SWTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $106.00 (+24.2%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/22/2021 Goldman Sachs
» Updated 7/20/2021
Corinne Jenkins New Coverage Buy
(N/A)
123.00
(107.00)
68.20
(85.36)
25.16% Details
5/5/2020 Barclays
» Updated 2/26/2021
Peter Lawson New Coverage Overweight
(N/A)
105.00
(92.00)
30.21
(85.36)
182.56% Details
Like SWTX Ratings? Also take a look at DTIL, PFE, ALLO, JAZZ

SWTX Ratings News